Vi värdesätter din integritet

Vi använder nödvändiga cookies för att webbplatsen ska fungera och Google Analytics för att mäta besök (det sätter cookies och påverkas inte av valen nedan). Med ditt samtycke använder vi också våra egna analyscookies för att förstå hur webbplatsen används och förbättra den. Integritetspolicy

XOOBAY 数贝环球
Jinhe Group
Jinhe Group

Jinhe Group

Premiumelit

Förfrågan
5
Produkter
0
Följare
2013
Grundat

Går till USA för att noteras | 6 företag inklusive Chengdaotong Environmental Protection och Yinhua Technology har fått krav på kompletterande material för registrering av utländska emissioner och not

Jinhe Group
Går till USA för att noteras | 6 företag inklusive Chengdaotong Environmental Protection och Yinhua Technology har fått krav på kompletterande material för registrering av utländska emissioner och not

Golden Box Group|Listed Guidance|US Listing|IPO|SPAC|RTO|US Listing|Professional US Listing Guidance Institution|US Stock Listing|

Today's Quick Overview of US Listing News!

On September 1st, the International Department of the China Securities Regulatory Commission (CSRC) issued supplementary material requirements to 7 companies, of which 6 are US IPOs and 1 is a Hong Kong IPO. Details below:

Zeekr Intelligent (confidential submission, filing notice issued) (NASDAQ)

Please your company to provide supplementary explanations on the following matters, and a lawyer shall verify and issue a clear legal opinion:

I. Regarding the equity structure, please provide supplementary explanations:

(1) The compliance of the establishment of the equity structure, including but not limited to the foreign exchange management, overseas investment and other regulatory procedures involved in the overseas establishment of the equity structure and round-trip M&A, and the payment of taxes in accordance with the law;

(2) The specific transaction arrangements between relevant entities, including but not limited to the time, amount, channels and methods of capital support for domestic entities, and the relevant capital flows and profit transfer arrangements.

II. Regarding changes in equity, please provide supplementary explanations:

(1) The similarities and differences between Pre-A round and A round preferred shares, whether there are special rights arrangements and their impact on the company's operation and control, and whether such impacts are still ongoing;

(2) The payment of consideration and tax payment for each share change since the issuer was established, the domestic regulatory procedures such as foreign exchange management and overseas investment that have been fulfilled; the latest progress in overseas investment procedures for shareholders of the proposed issued shares;

(3) The compliance of the employee stock ownership plan, including but not limited to the fulfillment of domestic regulatory procedures such as foreign exchange management for the employee stock ownership plan; whether there are unconfirmed grantees in the employee stock ownership plan; the reasons and background for non-issuer system employees to participate in the employee stock ownership plan, the source of funds, and whether there is profit transfer.

III. Regarding personal information protection and data security, please provide supplementary explanations:

The situation of products such as APPs and mini-programs developed and operated by your company, explain whether it involves providing information content to third parties, if so, explain the type of information content, and the measures for information content security protection, the scale of user information collected and stored by your company, the use of data, and the arrangements or measures for personal information protection and data security before and after listing.

DeepRoute.ai (confidential submission, filing notice issued) (NASDAQ)

Please your company to provide supplementary explanations on the following matters, and a lawyer shall verify and issue a clear legal opinion:

I. Regarding changes in equity:

(1) Please verify the compliance of the equity incentive plan, including but not limited to the fulfillment of domestic regulatory procedures such as foreign exchange management for the equity incentive plan, and explain whether there are external personnel or unconfirmed grantees in the equity incentive plan;

(2) Please list the amount, consideration payment and tax payment for each share change since the issuer was established, and the domestic regulatory procedures such as foreign exchange management and overseas investment that have been fulfilled;

(3) The similarities and differences between different types of preferred shares, whether there are differences in capital increase prices, whether there are special rights arrangements and their impact on the company's operation and control, and whether such impacts are still ongoing.

II. Regarding foreign investment access: the reasons why the adjusted contractual control structure does not involve businesses prohibited or restricted by foreign investment access in the "Special Management Measures for Foreign Investment Access (Negative List)" (2021 edition), the progress of canceling relevant qualifications, and whether it has a material impact on the company's business operation.

III. Regarding the equity structure:

(1) The compliance of the equity control structure, including but not limited to the foreign exchange management, overseas investment and other regulatory procedures involved in the establishment and round-trip M&A, and the payment of taxes in accordance with the law;

(2) The specific transaction arrangements between relevant entities under the equity control structure, including but not limited to the time, amount, channels and methods of capital support for domestic entities, and the relevant capital flows and profit transfer arrangements.

HealthTech Holdings (confidential submission to public) (NASDAQ)

Please your company to provide supplementary explanations on the following matters, and a lawyer shall verify and issue a clear legal opinion:

I. Regarding your company's equity structure, please explain:

(1) The consideration, pricing basis and payment of consideration and taxes (if any) when 6 individual shareholders including Fan Zhen transferred the equity of the domestic operating entity Beijing HealthTech to WOFE company HealthTech in October 2022;

(2) The source of funds for shareholder Wu Hongli to subscribe for the issuer's equity, and the fulfillment of regulatory procedures such as foreign exchange management;

(3) The reasons and rationality for Beijing HealthTech to introduce shareholders Wu Hongli, Zhao Tao, Sun Wenpu and Li Han through capital increase;

(4) The reasons and compliance for Beijing HealthTech's registered capital not being fully paid, and its impact on the company's operation and solvency.

II. Regarding operational compliance, please explain:

(1) Whether your company's business operations comply with regulations such as the "Measures for the Administration of Medical Advertising" and the "Notice on In-depth Development of Internet Advertising Rectification Work";

(2) The situation and scale of personal information collected, used, analyzed and stored, the arrangements or measures taken for personal information protection and data security, and whether they comply with national personal information protection laws and regulations;

(3) The basis for determining the rebate ratio, whether the internal governance and monitoring measures related to the rebate model are sound, and whether there are off-book rebates or other violations of laws and regulations such as the "Anti-Unfair Competition Law of the People's Republic of China".

III. Please supplement the specific situation of your company's current issuance and listing plan in accordance with the requirements of the "Guidelines for Regulatory Application - Overseas Issuance and Listing No. 2: Guidelines for the Content and Format of Filing Materials", including but not limited to the number of shares issued, the estimated amount of raised funds, etc.

Hardening Technology (NASDAQ)

Please your company to provide supplementary explanations on the following matters, and a lawyer shall verify and issue a clear legal opinion:

I. Regarding the equity structure, please explain:

(1) The correspondence between the ultimate shareholders of major shareholder Hinomoto Limited and Redarmor Inc. and the ultimate shareholders of major domestic operating entity Zhongshan Siterwell's original shareholders Zhongshan Red Armor Investment Management Partnership (Limited Partnership) and Zhongshan Hesu Management Consulting Partnership (Limited Partnership);

(2) The pricing basis and fairness of Chen Nianchun's capital increase in Zhongshan Siterwell in May 2021 and the acquisition of Zhongshan Siterwell's equity by the issuer's domestic subsidiary Zhongshan Hewell, the timely declaration and payment of relevant taxes for the above equity transfers, and whether the reporting obligations stipulated in the "Measures for Foreign Investment Information Reporting" have been fulfilled.

II. Regarding changes in equity, please provide a conclusive opinion on the legality and compliance of share changes since the establishment of major domestic operating entity Zhongshan Siterwell.

III. Regarding special verification, please a lawyer to issue a clear overall conclusive opinion on whether there are circumstances in the "Trial Measures" Article 8 that prohibit overseas issuance and listing for this issuance.

Citydo Environmental Protection (NASDAQ)

Please your company to provide supplementary explanations on the following matters, and a lawyer shall verify and issue a clear legal opinion:

I. Regarding the equity structure, please explain:

(1) The pricing basis and fairness of Hong Kong Citydo and Hong Kong Chaoxiong Investment's acquisition of all equity of Shenzhen Citydo through M&A in 2015, the timely declaration and payment of relevant taxes for the above equity transfers, and whether the reporting obligations stipulated in the "Measures for Foreign Investment Information Reporting" have been fulfilled;

(2) The specific reason why Li Yunwu has not completed the 37th article change registration since he acquired the shares of special purpose companies held by Luo Zhijian and Li Hong respectively in 2015;

(3) The equity structure diagram of the subsidiary is inconsistent with the equity structure diagram attached to the legal opinion, please provide the final version of the equity structure diagram;

(4) The reasons and compliance for the registered capital of major domestic operating entity Shenzhen Citydo not being fully paid, and whether it has a material impact on the company's business operation and solvency;

(5) The basis for determining the transfer price and fairness when selling the equity of the Xiamen subsidiary for 5000 US dollars in 2022.

II. Regarding shareholder information, please list the establishment time, type and operation mode, term, rights and obligations of the parties, and beneficiaries of the upper trust Harneys Trustees Limited of shareholder Luo Jia Holdings Limited.

Contineo (NASDAQ)

Please your company to provide supplementary explanations on the following matters, and a lawyer shall verify and issue a clear legal opinion:

The tax declaration and payment situation of the asset acquisition and reorganization between your company and CATALYST BIOSCIENCES, INC. in accordance with the relevant provisions of the "Announcement on Issues Concerning Enterprise Income Tax for Indirect Transfer of Property by Non-Resident Enterprises".

On the same day, the CSRC also updated the filing situation of overseas securities issuance and listing by domestic enterprises (initial public offering and full circulation) (as of August 31, 2023), with a total of 105 domestic enterprises filed (excluding enterprises that have completed).

9 new enterprises were added last week, 8 going to Hong Kong and 1 going to the US. The 9 enterprises are: Cenchi Mobility, Baicha Baida, Black Sesame Intelligent Technology, Zhongshan Jianye, Fendan Technology (US listing), Marlen Healthcare, Sanhua Intelligent Controls, Vericor Life Sciences, and SF Holding.

The list of newly added enterprises last week is as follows:

fad7681271db260284bbc643c8f630ab_640_wx_fmt=png&wxfrom=5&wx_lazy=1&wx_co=1.png

Kinesiska bolag som listas på amerikanska börser återhämtar sig,processen för godkännande av registrering för utgivning och listning av företag utomlands har påskyndats,2023年den amerikanska aktiemarknaden har en stark uppgång,kinesiska företag som listas i USA har allt större förtroende. Jinhe Group Xiaojin kommer dagligen att dela med sig av het information om listning i USA för att hjälpa företag att lyfta i listningen!

Friskrivningsklausul: En del information i denna artikel kommer från internet, innehållet i denna artikel publiceras endast i delningssyfte. Om det gäller innehåll eller upphovsrättsfrågor, vänligen kontakta oss, vi kommer att hantera det inom första tid!

Ursprungligen publicerad på 金盒企业管理集团